TOXICITY OF CYCLOSPORINE METABOLITES

被引:40
作者
COPELAND, KR
THLIVERIS, JA
YATSCOFF, RW
机构
[1] UNIV MANITOBA,HLTH SCI CTR,HLTH SCI CLIN RES CTR,DEPT CLIN CHEM,WINNIPEG R3T 2N2,MANITOBA,CANADA
[2] UNIV MANITOBA,HLTH SCI CTR,HLTH SCI CLIN RES CTR,DEPT ANAT,WINNIPEG R3T 2N2,MANITOBA,CANADA
关键词
Cyclosporine; Metabolites; Toxicity;
D O I
10.1097/00007691-199011000-00003
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Eight cyclosporine (CsA) metabolites were isolated from the urine of renal transplant recipients. The structure and purity of the metabolites were characterized by fast atom bombardment/mass spectroscopy as well as by proton and 13C nuclear magnetic resonance. The in vitro toxicity of the metabolites were tested using a porcine renal epithelial cell line (LLC-PK1). None of the metabolites was as effective as CsA in inhibiting cell growth and DNA, RNA, or protein synthesis, with the majority of them exhibiting activity less than 10% of that of CsA when the IC50 (the concentration required for 50% inhibition of that particular metabolic function) values were compared. The exception to this was the demethylated metabolite M-21, which exhibited a potency of 17–50% of CsA for the various metabolic parameters examined. The results suggest that the immunosuppressive activity of metabolites may be dissociated from their toxicity. Morphologically, CsA and the metabolite M-21 resulted in changes consistent with the vacuolization seen in tubular cells exposed to CsA in vivo. In contrast, M-17 up to the maximum concentration tested (25,000 μg/L) was found not to cause such changes. © 1990 Raven Press, Ltd.
引用
收藏
页码:525 / 532
页数:8
相关论文
共 22 条
  • [1] BECKER GM, 1987, RES COMMUN CHEM PATH, V56, P277
  • [2] BERGSTRAND A, 1985, CLIN NEPHROL, V24, P107
  • [3] BOREL JF, 1989, TRANSPL P, V21, P810
  • [4] COLE E, 1989, TRANSPLANT P, V21, P943
  • [5] COPELAND KR, 1990, TRANSPLANT P, V32, P225
  • [6] INVITRO IMMUNOSUPPRESSIVE PROPERTIES OF CYCLOSPORINE METABOLITES
    FREED, BM
    ROSANO, TG
    LEMPERT, N
    [J]. TRANSPLANTATION, 1987, 43 (01) : 123 - 127
  • [7] HALL RN, 1976, IN VITRO, V12, P670
  • [8] HARTMAN NR, 1987, DRUG METAB DISPOS, V15, P661
  • [9] LENSMEYER GL, 1988, TRANSPLANT P, V20, P614
  • [10] LENSMEYER GL, 1989, CLIN CHEM, V35, P56